Activities of endothelin-1 in the vascular network of the rabbit ear: a microangiographic study
- PMID: 2085704
- PMCID: PMC1917830
- DOI: 10.1111/j.1476-5381.1990.tb14157.x
Activities of endothelin-1 in the vascular network of the rabbit ear: a microangiographic study
Abstract
1. The effects of endothelin-1 on perfusion pressure and on arterial and venous diameters were examined simultaneously in a rabbit isolated ear preparation perfused with physiological buffer. The effects of hypoxia and inhibition of endothelium-derived relaxant factor (EDRF) activity on vascular responses to endothelin-1 were also investigated. 2. Endothelin-1 was potent at increasing perfusion pressure (ED50 = 46.7 +/- 11.0 pmol; Rmax = 85.3 +/- 5.3 mmHg). The potency and maximum reactivity were not significantly affected by hypoxia, inhibition of EDRF activity with 50 microns N-nitro-L-arginine methyl ester (NAME) or a combination of hypoxia and NAME. 3. Endothelin-1 caused equipotent dose-dependent constrictions of the first four generations of arterial branch vessels (G1-G4) but did not influence the diameter of the central ear artery except at high doses of the peptide when paradoxical dilatation' was observed. The peptide was also equipotent at causing constriction of the smaller venous vessels (V1-V4) but did not affect the large veins (V0). 4. Under conditions of hypoxia the potency of endothelin-1 was reduced in G2 and G3, was unaffected in G4 and the peptide did not significantly constrict either G0 or G1. Hypoxia reduced the potency of endothelin-1 in the smaller venous vessels (V1-V4), but conversely unmasked a marked constriction of the large veins (V0), which was not observed under normoxic conditions. 5. NAME 50 micron abolished the vasodilator effects of acetylcholine in this preparation. Inhibition of EDRF activity with NAME under normoxic conditions did not influence the constrictor activity of endothelin-1 on the arterial or venous branch vessels. However, inhibition of EDRF activity under hypoxic conditions prevented the reduction of potency of endothelin-1 as a constrictor of arterial and venous branch vessels which occurred in hypoxia. In the presence of NAME endothelin-1 constricted VO in both normoxia and hypoxia with equipotency but the maximum effect was greatest in hypoxia. 6. In conclusion, endothelin-1 is a powerful vasoconstrictor which acts with greater potency in veins than arteries in the rabbit isolated ear. Although hypoxia does not influence pressor responses it nevertheless alters the spatial pattern of vasoconstriction. In particular hypoxia unmasks constriction of the large veins by endothelin-1. Constriction of these veins was also observed in the absence of EDRF in normoxia, but to a much lesser degree so that the effect of hypoxia may only be partially due to reduced EDRF activity. Hypoxia may therefore directly or indirectly increase the sensitivity of the main veins to endothelin-1.
Similar articles
-
Differential effects of L-arginine on the inhibition by NG-nitro-L-arginine methyl ester of basal and agonist-stimulated EDRF activity.Br J Pharmacol. 1991 Nov;104(3):743-9. doi: 10.1111/j.1476-5381.1991.tb12498.x. Br J Pharmacol. 1991. PMID: 1797335 Free PMC article.
-
Endothelium-dependent vascular activities of endothelin-like peptides in the isolated superior mesenteric arterial bed of the rat.Br J Pharmacol. 1990 Sep;101(1):81-8. doi: 10.1111/j.1476-5381.1990.tb12093.x. Br J Pharmacol. 1990. PMID: 2282471 Free PMC article.
-
Endothelial modulation and changes in endothelin pressor activity during hypoxia in the rat isolated perfused superior mesenteric arterial bed.Br J Pharmacol. 1991 Jun;103(2):1441-8. doi: 10.1111/j.1476-5381.1991.tb09808.x. Br J Pharmacol. 1991. PMID: 1884099 Free PMC article.
-
Does endothelin-1 mediate endothelium-dependent contractions during anoxia?J Cardiovasc Pharmacol. 1989;13 Suppl 5:S124-8; discussion S142. doi: 10.1097/00005344-198900135-00031. J Cardiovasc Pharmacol. 1989. PMID: 2473285 Review.
-
Vascular activities of the endothelins.Pharmacol Ther. 1991;50(1):73-93. doi: 10.1016/0163-7258(91)90073-u. Pharmacol Ther. 1991. PMID: 1653963 Review.
Cited by
-
Effects of BRL 38227, sodium nitroprusside and verapamil on collateral perfusion following acute arterial occlusion in the rabbit isolated ear.Br J Pharmacol. 1992 Jun;106(2):315-23. doi: 10.1111/j.1476-5381.1992.tb14334.x. Br J Pharmacol. 1992. PMID: 1393264 Free PMC article.
-
Differential effects of L-arginine on the inhibition by NG-nitro-L-arginine methyl ester of basal and agonist-stimulated EDRF activity.Br J Pharmacol. 1991 Nov;104(3):743-9. doi: 10.1111/j.1476-5381.1991.tb12498.x. Br J Pharmacol. 1991. PMID: 1797335 Free PMC article.
-
Modulation of vasodilatation to levcromakalim by hypoxia and EDRF in the rabbit isolated ear: a comparison with pinacidil, sodium nitroprusside and verapamil.Br J Pharmacol. 1993 Jun;109(2):386-93. doi: 10.1111/j.1476-5381.1993.tb13581.x. Br J Pharmacol. 1993. PMID: 8358541 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous